ABSTRACT OBJECTIVE: Adequate dietary iodine intake is necessary for normal thyroid gland function at all times, and most particularly during pregnancy. Increased iodine loss is cited, among other factors, as responsible for the increased iodine demand in this period. Our aim was to compare renal iodine excretion between women during all three pregnancy trimesters with that of their spouses and thereby to estimate the iodine intake in an a large sample of pregnant women in urban areas in Greece. DESIGN: Four hundred twenty-four healthy pregnant women were included prospectively (residents of Athens n=218, residents of Patras n=206). The spouses of 177 of these women following the same diet were also studied. Determinations included serum FT4, TSH and aTPO and urinary iodine excretion (UIE). RESULTS: No difference was found either in median UIE throughout pregnancy or between the UIE of the pregnant women and their spouses during the trimesters. Throughout pregnancy, mild iodine deficiency was noted and was classified as mild in 60%, moderate in 30% and severe in 10% of the women studied. Users of iodized salt had significantly higher median UIE compared with non-users. Serum FT4 levels decreased and TSH increased as pregnancy progressed. CONCLUSIONS: Our study indicates that renal iodine excretion is not increased during pregnancy. This finding needs to be confirmed by further investigation in other populations with different iodine intakes. Thus, increased iodine requirements in pregnancy are possibly due to extra-renal causes. The population of pregnant women in Greek urban areas is mildly-and often moderately and severely-iodopenic and needs to be treated accordingly.
INTRODUCTION
Iodine is an essential component of the hormones synthesized by the thyroid gland. Inadequate dietary iodine intake in pregnancy can lead to goiter and ab-normal development of the fetal nervous system and can have long-term adverse effects on the offspring's cognitive function, which might not be ameliorated by iodine sufficiency during childhood. [1] [2] [3] [4] The frequency of odine deficiency disorders (IDD) is minimal in Western European and in many Central and Eastern European countries. 5, 6 However, partially inadequate dietary iodine intake is present in Europe, as well as in the USA, in pregnant and breastfeeding women, [7] [8] [9] [10] [11] [12] [13] who have increased daily requirements. WHO recommends a minimum UIE of 150 mcg/L for pregnant and breastfeeding women as a marker of adequate dietary intake, 7 whereas for the general population the lower normal limit is set at 100 mcg/L. 7 The renal iodine clearance results chiefly from glomerular filtration, with no evidence for tubular secretion or active transport. It is generally accepted that glomerular filtration and hence renal excretion of iodine increases from the first weeks of pregnancy, resulting in a constant iodine "loss". 14 In iodine sufficient environments, where thyroid iodine stores in the body are full, this loss may result in creating an inadequate substrate for thyroid hormone production, without causing any dysfunction. However, in iodine non-sufficient/deficient environments, the normal adaptation mechanisms are ineffective, resulting in increased TSH and decreased FT4 concentrations and in goiter development. 15 In Greece, the study and management strategies of iodine deficiency were initiated 40 years ago, when iodopenic goiter was endemic. Over the years, a gradual amelioration of this adverse situation was noted mostly due to the increased use of iodized salt as well as to an overall improvement in quality of life. At the beginning of the 1980's, median UIE in Athens was 94 mcg/L, which corresponds, according to the WHO criteria, to mild iodine deficiency. 16 After 2000, several studies were conducted in various regions of the country. In Southwestern Greece, median UIE was found to be 114 mcg/L, corresponding to marginally adequate daily iodine intake. 17 Another study conducted in Epirus, Northwestern Greece, which is one of the poorer European Union mountainous region, showed that the population studied was mildly iodine deficient 18 as compared to people living in Athens whose median UIE was 310 mcg/L and the prevalence of goiter 4%, denoting iodine sufficiency. 18 However, not much data exist with respect to the sensitive population of pregnant women. In a recent preliminary study of our team in a small number of pregnant women in the greater Athens area, during the first trimester of their pregnancies, median UIE was <100 mcg/L in more than 50% of the cases. Furthermore, 1/3 of them had median UIE <50 mcg/L. These values indicate mild and moderate iodine deficiency respectively. 19 In the present study, UIE was measured in pregnant women throughout all three pregnancy trimesters in two big cities, Athens and Patras, and compared to that of their spouses on the same diet. Our primary goal was to compare renal iodine excretion between the two teams, that is wives vs. husbands, and our secondary objective was to estimate UIE in a large sample of pregnant women living in urban Greek areas.
MATERIALS AND METHODS
The study was conducted in two hospitals: the "Elena Venizelou" Maternity Hospital in Athens and the University Hospital of Patras. Four hundred and twenty-four healthy, pregnant women with a mean age of 30 years were included in the study, irrespective of the pregnancy trimester (Athens n=218, Patras n=206). Some of them (n=126) were studied during more than one trimester. Two hundred and twelve observations in the 1 st trimester, 131 in the 2nd and 152 in the 3rd were collected. One hundred and seventy-seven of the women (Group 1) were compared with their healthy spouses on the same diet (Group 2), regardless of the pregnancy trimester. All participants were euthyroid without a past history of thyroid disease. None was taking iodine containing preparations. All women completed a special questionnaire documenting anthropometric (age, body weight, height) and obstetric data (week of gestation) (Table 1) , and a subset of them furnished data regarding the use of iodized salt. All subjects provided informed consent.
UIE was measured twice in a spot sample collected on two different days and the mean value was used. Blood samples were centrifuged and the sera were frozen at -20 o C until hormonal determinations were performed, which was carried out at the Hormonal Laboratory of the University Hospital of Patras. Serum FT4, TSH and aTPO were determined by electrochemiluminescence (Elecsys 2010, Roche Diagnostics) and urine iodine excretion (UIE) by a photometric method (Sandell-Kolthoff reaction). 20 Our laboratory is taking part in an external evaluation program for urinary iodine excretion determination conducted by the EQUIP Program (Atlanta, USA). The study was approved by both hospitals' Ethics Committees.
Statistics
All statistical procedures were performed using SPSS for Windows, version 9.0.1 (Chicago, Illinois, 6061 USA). The normality of UIE, TSH, FT4 and Tg distributions were checked by the One-Sample Kolmogorov-Smirnov test. Differences among the three trimesters for the UIE, TSH, FT4 and Tg were evaluated by the independent-samples Kruskal-Wallis test. When the p-value from the abovementioned test statistics was significant, the Mann-Whitney U test was performed to determine the groups that differed from each other. Comparisons between Groups 1 and 2 were performed by the Mann-Whitney U test. A P value less of than 0.05 was considered significant.
RESULTS
The median UIE of the 177 women (Group 1) as a whole was 135.9 (20-628.1 mcg/L), similar to the median UIE of their spouses (Group 2) 138.4 (range 20.9-560.4mcg/L), the latter categorizing them (Group 2) as iodine sufficient according to the WHO. Interestingly, comparison of Group 1 vs Group 2 revealed no significant difference between UIE in any pregnancy trimester (Table 2) .
After dividing Group 2 (men) into those with less than optimal (UIE <150 mcg/L), optimal (UIE 150-250 mcg/L) and excess (UIE >250 mcg/L) iodine intake according to the WHO criteria, no significant difference between the UIE of pregnant women and their paired spouses in any pregnancy trimester was found in the optimal UIE group (Table 3a ).
In the less than optimal group according the men's UIE, the pregnant women had significantly higher UIE compared to their spouses, while exactly the opposite was found in the iodine excess group (Table  3b and Table 3c ).
Thyroid hormones exhibited the expected changes with the progression of pregnancy. Specifically, from Table 4 .
Mild iodine deficiency was noted in all trimesters of pregnancy, this finding applying to women from both cities studied (Athens: median UIE = 123 / range = 21 -620 mcg/L, Patras: median UIE = 136 / range = <20 -628 mcg/L, 0.21). Iodine deficiency was present through all pregnancy trimesters in a significant proportion of the subjects studied (Table 5 ). Users of iodized salt had statistically significantly higher UIE compared with non-users (medianL (range): users (n=108) 145 mcg/L (<20-628), non-users (n=68) 117 mcg/L (23-31), p <0.05.
DISCUSSION
The major advantage of this study is the concurrent estimate of UIE in pregnant women and their husbands both following the exact same diet. We observed no difference in urinary iodine excretion between pregnant women and their spouses as a whole, as well as when calculated according to pregnancy trimester. Mild iodine deficiency-estimated by determination of the median value for UIE-was noted in women from both cities, with a significant percentage presenting moderate or even severe iodine deficiency (30% and 10%, respectively).
The presumed increase in renal iodine excretion during pregnancy dates back to the 1960's and has been quoted in various textbooks as "classical" knowledge since then. 13, 14 Old studies are scarce and difficult to evaluate in the present, while the classic techniques to evaluate glomerular filtration cannot be performed in pregnant women for obvious reasons. Thus, measuring renal iodine clearance is the only applicable technique. A specialized laboratory for plasma inorganic iodine determination is essential. The Hormonal Laboratory of the University Hospital of Patras possesses the technical knowhow to accurately measure UIE and is moreover participating in a relevant external evaluation program. However, simultaneous reliable plasma iodine concentration determination tends to be the international gold standard method and our laboratory is also working in order to establish this method, in line with its reference laboratory. To date, renal iodine loss in pregnancy can only be estimated 0.324 * p <0.01 1st vs 2nd trimester; ** p< 0.05 1st vs 3rd trimester; † p < 0.01 1st vs 3rd trimester; ‡ p < 0.01 2nd vs 3rd trimester. indirectly. Few studies have examined changes in UIE across pregnancy and those have produced varying results: some show increasing values across trimesters, some decreasing values and some no change, possibly based on the underlying iodine sufficiency of the populations studied. [21] [22] [23] [24] [25] Our present study is the first to concurrently estimate UIE in pregnant women and their husbands following the exact same diet as them. Taking into account that dietary intake is the exclusive iodine source 7 and that there was no difference in quality or quantity of daily food intake consumed by each couple (as documented by a special completed questionnaire), we assumed that UIE determination in both spouses would provide us with indirect information regarding the effect of pregnancy on renal iodine excretion. Our results showed that neither at the beginning of pregnancy nor with pregnancy progression is the renal iodine excretion of pregnant women increased, as the UIE presented no significant difference in each trimester and was no different from that of their husbands. If these results are accurate, to what should the increased iodine requirements of pregnancy be attributed? Apart from the urinary loss, another reason for increased iodine requirements in pregnancy is the 50% increase in thyroid hormone production, as noted above. Moreover, from the mid-second and during the third pregnancy trimesters, there is a constant iodine "output" from the mother to the fetus through the placenta, providing this essential compound to the fetal gland for thyroid hormone synthesis. Furthermore, it seems that the placenta is a sort of iodine store per se. 26, 27 Whether this iodine could have an embryo protective role under certain circumstances is still unknown.
When we examined the women's UIE by comparison with their spouse's iodine status, we found that there was no difference between their UIE and that of their spouses in the optimal UIE group, that is, UIE 150-250 mcg/L. This supports our hypothesis, at least in the presence of adequate iodine intake, as this has also been previously reported. 21 However, in the lowest tritile of UIE excretion (<150), women excreted less iodine throughtout pregnancy than their husbands, while in the highest tritile the contrary was found. These differences could be explained, as was suggested by Dworkin et al, by the existence of a urinary iodostat which is set according to iodine intake. 21, 28 Thyroid hormones presented the expected alterations: FT4 was found significantly higher in the 1 st in comparison to the 2 nd and 3rd trimesters, while, although TSH was lower in the first in comparison to the third trimester, both remained within normal limits. These alterations are attributed to the major increase in hCG in early pregnancy, which exerts a partial TSH action due to its -subunit homology. 29 Tg changes tend to represent normal fluctuations. Although the aTPO values tended to decrease with pregnancy progression, no significant difference in autoimmunity status was found, probably due to the relatively small sample size. It is accepted that pregnancy has a normal immunosuppressive effect and this also applies to thyroid autoimmunity. 30 Greece is currently considered as an iodine sufficient country with only a few isolated areas of mild iodine deficiency. 31 The results of the present study, in the small sample of husbands studied, confirm this observation. However, with respect to the population of pregnant women, at least those living in urban areas, However, mild iodine deficiency was present through all three pregnancy trimesters in our sample and was completely dependent on the level of iodized salt use. Recent studies in various countries have shown that even when UIE is within normal/acceptable limits, it is still lower than it was 20 years ago in the same populations. 32 Nevertheless, a significant percentage of adult reproductive aged/pregnant women have a UIE at or below the levels of iodine sufficiency, 33, 34 as suggested by the International Organizations, and this is also true in school-aged children in areas with adequate UIE. 33 A geographical variation regarding dietary iodine intake which is so pronounced that complementary iodine cannot eliminate it is plausible in these iodine-sufficient countries. 9 Moreover, it is to be noted that even in countries such as the USA and the United Kingdom where adequate iodine intake has been established for a long period of time, or countries where food is iodized, iodine deficiency is documented in pregnant women and women of reproductive age. 12, 32, 36, 37 In conclusion, the results of the present study indirectly indicate that renal iodine excretion is not increased during pregnancy. This finding needs to be confirmed by further studies among other populations with different iodine intakes. The increased iodine requirements of gestation are possibly due to extra-renal causes. The majority of pregnant women in Greek urban areas are mildly iodopenic, with a non-negligible percentage presenting moderate and severe iodine deficiency, this underlining the need for identification of the disorder and appropriate treatment.
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